This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback
Trial record 1 of 5 for:    Lumbar Isthmic Spondylolisthesis
Previous Study | Return to List | Next Study

Comparative Study of Anterior vs. Posterior Surgical Treatment for Lumbar Isthmic Spondylolisthesis (I-Spondy)

This study is currently recruiting participants.
See Contacts and Locations
Verified May 2017 by AOSpine North America Research Network
Sponsor:
Information provided by (Responsible Party):
AOSpine North America Research Network
ClinicalTrials.gov Identifier:
NCT02564705
First received: September 29, 2015
Last updated: May 26, 2017
Last verified: May 2017
  Purpose
The aim of this study is to compare outcomes and cost-effectiveness of anterior versus posterior surgical treatment for lumbar Isthmic Spondylolisthesis. The primary objective is to compare treatment effectiveness in terms of functional outcomes as measured by Oswestry Disability Index (ODI) v2.1a and to compare safety outcomes measured by treatment-related adverse events. Secondary objectives are to compare treatments in terms of differences in pain, quality of life, health utilities, and need for re-operation. Finally, a cost-effectiveness analysis will be performed. This analysis will take the form of cost-effectiveness if there is a difference in treatment effects or cost-minimization if there is no difference in treatment efficacy.

Condition Intervention
Isthmic Spondylolisthesis Procedure: Anterior Lumbar Interbody Fusion (ALIF) Procedure: Posterior Fusion

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: A Multi-Center, Prospective, Comparative Study of Anterior vs. Posterior Surgical Treatment for Lumbar Isthmic Spondylolisthesis

Further study details as provided by AOSpine North America Research Network:

Primary Outcome Measures:
  • Change in Oswestry Disability Index Score v2.1a [ Time Frame: between pre-operative and 730 days (24 months) ]

Secondary Outcome Measures:
  • Change in Numeric Pain Rating Scale (Pain NRS) for low back pain [ Time Frame: between pre-operative and 730 days (24 months) ]
  • Change in EQ-5D-3L health utility index [ Time Frame: between pre-operative and 730 days ]

Estimated Enrollment: 180
Study Start Date: February 2016
Estimated Study Completion Date: May 2019
Estimated Primary Completion Date: May 2019 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
anterior cohort
Anterior Lumbar Interbody Fusion (ALIF)
Procedure: Anterior Lumbar Interbody Fusion (ALIF)
posterior cohort
  • Posterolateral Fusion (PLF)
  • Posterior Lumbar Interbody Fusion (PLIF)
  • Transforaminal Lumbar Interbody Fusion (TLIF)
Procedure: Posterior Fusion
  • Posterolateral Fusion (PLF)
  • Posterior Lumbar Interbody Fusion (PLIF)
  • Transforaminal Lumbar Interbody Fusion (TLIF)

  Eligibility

Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with Isthmic spondylolisthesis (IS)
Criteria

Inclusion Criteria:

  • Aged 18 to 80 years, inclusive
  • Grade I, II or III (less than 75% slip of the cephalad vertebra compared to the caudal vertebra) isthmic spondylolisthesis at single level between L4 and S1
  • Unresponsive to a minimum of 3 months of non-surgical treatment
  • No previous surgical treatment for isthmic spondylolisthesis
  • Patients who are medically suitable for surgical management
  • Patients who have consented for surgical treatment
  • Willing and able to comply with the Investigational Protocol (IP)
  • Informed Consent Form (ICF) signed by patient

Exclusion Criteria:

  • Any previous lumbar spine surgery
  • Patient has significant scoliosis (Cobb angle is greater than 25 degrees)
  • Subject has cauda equina syndrome defined as neural compression causing neurogenic bowel (rectal incontinence) or bladder (bladder retention or incontinence) dysfunction
  • Subject is pregnant or of child-bearing potential and not currently on adequate birth control method
  • Active infection at the surgical site
  • Recent history (less than 1 year) of chemical substance dependency or significant psychosocial disturbance that may impact the outcome or study participation, in the opinion of the Investigator
  • Pre-existent neurologic or mental disorder which would preclude accurate evaluation and follow-up (i.e. Alzheimer's disease, Parkinson's disease, unstable psychiatric disorder with hallucinations and/or delusions or schizophrenia
  • Participation in another clinical trial of drug or device within the past 30 days that could influence the outcomes of this study
  • Is a prisoner
  • Acquired immune deficiency syndrome (AIDS) or AIDS-related complex
  • Active malignancy or history of invasive malignancy within the last five years, with the exception of superficial basal cell carcinoma or squamous cell carcinoma of the skin that has been definitely treated; patients with carcinoma in situ of the uterine cervix treated definitely more than 1 year prior to enrollment may enter the study
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02564705

Contacts
Contact: Paul Arnold, MD (913) 588-7587 parnold@kumc.edu
Contact: Branko Kopjar, MD PhD (206) 607-6861 branko.kopjar@nor-consult.com

Locations
United States, California
University of California San Francisco Terminated
San Francisco, California, United States, 94143-0122
United States, Kansas
Kansas University Medical Center Recruiting
Kansas City, Kansas, United States, 66160
Contact: Paul Arnold, MD    913-558-7587    parnold@kumc.edu   
Contact: Linda Jianas    913-558-3252    ljianas@kumc.edu   
Principal Investigator: Paul Arnold, MD         
United States, Maryland
University of Maryland Medical Center Recruiting
Baltimore, Maryland, United States, 21201
Contact: Steven Ludwig, MD    410-328-8808    sludwig@umoa.umm.edu   
Contact: Luke Brown    (410) 328-8808    LBrown2@umoa.umm.edu   
Principal Investigator: Steven Ludwig, MD         
Johns Hopkins University Recruiting
Baltimore, Maryland, United States, 21287
Contact: Daniel Sciubba, MD    410-955-4424    dsciubb1@jhmi.edu   
Contact: Karim Ahmed       aahmed22@jhmi.edu   
Principal Investigator: Daniel Sciubba, MD         
United States, Missouri
University of Missouri Terminated
Columbia, Missouri, United States, 65212
Washington University Recruiting
Saint Louis, Missouri, United States, 63110
Contact: W. Zack Ray, MD    314-362-9959    rayz@wudosis.wustl.edu   
Contact: Aubrey Wright    314-362-3114    wrightau@wudosis.wustl.edu   
Principal Investigator: W. Zack Ray, MD         
United States, Ohio
Cleveland Clinic Recruiting
Cleveland, Ohio, United States, 44195
Contact: Thomas Mroz, MD    216-445-9232    MROZT@ccf.org   
Contact: Tracy Barbour    216-445-1741    Barbout@ccf.org   
United States, Pennsylvania
Thomas Jefferson University / Rothman Institute Recruiting
Philadelphia, Pennsylvania, United States, 19107
Contact: Alexander R. Vaccaro, MD, PhD    267-339-3578    alexvaccaro3@aol.com   
Contact: Mayan Lendner       mayan.lendner@rothmaninstitute.com   
Thomas Jefferson University Recruiting
Philadelphia, Pennsylvania, United States, 19107
Contact: James Harrop, MD    215-955-7000    james.harrop@jefferson.edu   
Contact: Pranoti Pradhan    (215) 955-2245    Pranoti.Pradhan@jefferson.edu   
Principal Investigator: James Harrop, MD         
United States, Utah
University of Utah Department of Orthopedics Recruiting
Salt Lake City, Utah, United States, 84108
Contact: Darrel Brodke, MD    801-587-5450    darrel.brodke@hsc.utah.edu   
Contact: Ashley Neese    (801) 587-5430    Ashley.Neese@hsc.utah.edu   
Principal Investigator: Darrel Brodke, MD         
United States, Virginia
University of Virginia Department of Neurosurgery Recruiting
Charlottesville, Virginia, United States, 22908
Contact: Christopher Shaffrey, MD    434-243-9728    CIS8Z@hscmail.mcc.virginia.edu   
Contact: Judy Beenhakker    (434) 982-1856    jgb3p@virginia.edu   
Principal Investigator: Christopher Shaffrey, MD         
United States, Washington
Swedish Medical Center Recruiting
Seattle, Washington, United States, 98122
Contact: Jens Chapman, MD    206-731-3466    Jens.Chapman@swedish.org   
Contact: Carol Kemp    (206) 320-2334    Carol.Kemp@swedish.org   
Canada, Ontario
Toronto Western Hospital Recruiting
Toronto, Ontario, Canada, M5T 2S8
Contact: Michael Fehlings, MD, PhD    (416) 603-5627    Michael.Fehlings@uhn.on.ca   
Contact: Yuriy Petrenko    (416) 603-5285    yuriy.petrenko@uhn.on.ca   
Principal Investigator: Michael Fehlings, MD, PhD         
Sponsors and Collaborators
AOSpine North America Research Network
  More Information

Responsible Party: AOSpine North America Research Network
ClinicalTrials.gov Identifier: NCT02564705     History of Changes
Other Study ID Numbers: SPN-14-001
Study First Received: September 29, 2015
Last Updated: May 26, 2017

Additional relevant MeSH terms:
Spondylolisthesis
Spondylolysis
Spondylosis
Spinal Diseases
Bone Diseases
Musculoskeletal Diseases

ClinicalTrials.gov processed this record on September 21, 2017